約 6,405,437 件
https://w.atwiki.jp/touhoukashi/pages/828.html
【登録タグ Alstroemeria Records Double Counterpoint S mican* オリジナル 曲】 【注意】 現在、このページはJavaScriptの利用が一時制限されています。この表示状態ではトラック情報が正しく表示されません。 この問題は、以下のいずれかが原因となっています。 ページがAMP表示となっている ウィキ内検索からページを表示している これを解決するには、こちらをクリックし、ページを通常表示にしてください。 /** General styling **/ @font-face { font-family Noto Sans JP ; font-display swap; font-style normal; font-weight 350; src url(https //img.atwikiimg.com/www31.atwiki.jp/touhoukashi/attach/2972/10/NotoSansCJKjp-DemiLight.woff2) format( woff2 ), url(https //img.atwikiimg.com/www31.atwiki.jp/touhoukashi/attach/2972/9/NotoSansCJKjp-DemiLight.woff) format( woff ), url(https //img.atwikiimg.com/www31.atwiki.jp/touhoukashi/attach/2972/8/NotoSansCJKjp-DemiLight.ttf) format( truetype ); } @font-face { font-family Noto Sans JP ; font-display swap; font-style normal; font-weight bold; src url(https //img.atwikiimg.com/www31.atwiki.jp/touhoukashi/attach/2972/13/NotoSansCJKjp-Medium.woff2) format( woff2 ), url(https //img.atwikiimg.com/www31.atwiki.jp/touhoukashi/attach/2972/12/NotoSansCJKjp-Medium.woff) format( woff ), url(https //img.atwikiimg.com/www31.atwiki.jp/touhoukashi/attach/2972/11/NotoSansCJKjp-Medium.ttf) format( truetype ); } rt { font-family Arial, Verdana, Helvetica, sans-serif; } /** Main table styling **/ #trackinfo, #lyrics { font-family Noto Sans JP , sans-serif; font-weight 350; } .track_number { font-family Rockwell; font-weight bold; } .track_number after { content . ; } #track_args, .amp_text { display none; } #trackinfo { position relative; float right; margin 0 0 1em 1em; padding 0.3em; width 320px; border-collapse separate; border-radius 5px; border-spacing 0; background-color #F9F9F9; font-size 90%; line-height 1.4em; } #trackinfo th { white-space nowrap; } #trackinfo th, #trackinfo td { border none !important; } #trackinfo thead th { background-color #D8D8D8; box-shadow 0 -3px #F9F9F9 inset; padding 4px 2.5em 7px; white-space normal; font-size 120%; text-align center; } .trackrow { background-color #F0F0F0; box-shadow 0 2px #F9F9F9 inset, 0 -2px #F9F9F9 inset; } #trackinfo td ul { margin 0; padding 0; list-style none; } #trackinfo li { line-height 16px; } #trackinfo li nth-of-type(n+2) { margin-top 6px; } #trackinfo dl { margin 0; } #trackinfo dt { font-size small; font-weight bold; } #trackinfo dd { margin-left 1.2em; } #trackinfo dd + dt { margin-top .5em; } #trackinfo_help { position absolute; top 3px; right 8px; font-size 80%; } /** Media styling **/ #trackinfo .media th { background-color #D8D8D8; padding 4px 0; font-size 95%; text-align center; } .media td { padding 0 2px; } .media iframe nth-of-type(n+2) { margin-top 0.3em; } .youtube + .nicovideo, .youtube + .soundcloud, .nicovideo + .soundcloud { margin-top 0.75em; } .media_section { display flex; align-items center; text-align center; } .media_section before, .media_section after { display block; flex-grow 1; content ; height 1px; } .media_section before { margin-right 0.5em; background linear-gradient(-90deg, #888, transparent); } .media_section after { margin-left 0.5em; background linear-gradient(90deg, #888, transparent); } .media_notice { color firebrick; font-size 77.5%; } /** Around track styling **/ .next-track { float right; } /** Infomation styling **/ #trackinfo .info_header th { padding .3em .5em; background-color #D8D8D8; font-size 95%; } #trackinfo .infomation_show_btn_wrapper { float right; font-size 12px; user-select none; } #trackinfo .infomation_show_btn { cursor pointer; } #trackinfo .info_content td { padding 0 0 0 5px; height 0; transition .3s; } #trackinfo .info_content ul { padding 0; margin 0; max-height 0; list-style initial; transition .3s; } #trackinfo .info_content li { opacity 0; visibility hidden; margin 0 0 0 1.5em; transition .3s, opacity .2s; } #trackinfo .info_content.infomation_show td { padding 5px; height 100%; } #trackinfo .info_content.infomation_show ul { padding 5px 0; max-height 50em; } #trackinfo .info_content.infomation_show li { opacity 1; visibility visible; } #trackinfo .info_content.infomation_show li nth-of-type(n+2) { margin-top 10px; } /** Lyrics styling **/ #lyrics { font-size 1.06em; line-height 1.6em; } .not_in_card, .inaudible { display inline; position relative; } .not_in_card { border-bottom dashed 1px #D0D0D0; } .tooltip { display flex; visibility hidden; position absolute; top -42.5px; left 0; width 275px; min-height 20px; max-height 100px; padding 10px; border-radius 5px; background-color #555; align-items center; color #FFF; font-size 85%; line-height 20px; text-align center; white-space nowrap; opacity 0; transition 0.7s; -webkit-user-select none; -moz-user-select none; -ms-user-select none; user-select none; } .inaudible .tooltip { top -68.5px; } span hover + .tooltip { visibility visible; top -47.5px; opacity 0.8; transition 0.3s; } .inaudible span hover + .tooltip { top -73.5px; } .not_in_card span.hide { top -42.5px; opacity 0; transition 0.7s; } .inaudible .img { display inline-block; width 3.45em; height 1.25em; margin-right 4px; margin-bottom -3.5px; margin-left 4px; background-image url(https //img.atwikiimg.com/www31.atwiki.jp/touhoukashi/attach/2971/7/Inaudible.png); background-size contain; background-repeat no-repeat; } .not_in_card after, .inaudible .img after { content ; visibility hidden; position absolute; top -8.5px; left 42.5%; border-width 5px; border-style solid; border-color #555 transparent transparent transparent; opacity 0; transition 0.7s; } .not_in_card hover after, .inaudible .img hover after { content ; visibility visible; top -13.5px; left 42.5%; opacity 0.8; transition 0.3s; } .not_in_card after { top -2.5px; left 50%; } .not_in_card hover after { top -7.5px; left 50%; } .not_in_card.hide after { visibility hidden; top -2.5px; opacity 0; transition 0.7s; } /** For mobile device styling **/ .uk-overflow-container { display inline; } #trackinfo.mobile { display table; float none; width 100%; margin auto; margin-bottom 1em; } #trackinfo.mobile th { text-transform none; } #trackinfo.mobile tbody tr not(.media) th { text-align left; background-color unset; } #trackinfo.mobile td { white-space normal; } document.addEventListener( DOMContentLoaded , function() { use strict ; const headers = { title アルバム別曲名 , album アルバム , circle サークル , vocal Vocal , lyric Lyric , chorus Chorus , narrator Narration , rap Rap , voice Voice , whistle Whistle (口笛) , translate Translation (翻訳) , arrange Arrange , artist Artist , bass Bass , cajon Cajon (カホン) , drum Drum , guitar Guitar , keyboard Keyboard , mc MC , mix Mix , piano Piano , sax Sax , strings Strings , synthesizer Synthesizer , trumpet Trumpet , violin Violin , original 原曲 , image_song イメージ曲 }; const rPagename = /(?=^|.*
https://w.atwiki.jp/mrfrtech/pages/13.html
Market Scenario According to Market Research Future, the global digital payment in healthcare market has been segmented based on component, deployment mode, organization size, and region/country. The major factors boosting market growth are increasing internet penetration and the digitalization in the healthcare vertical. Furthermore, there has been a significant increase in the adoption of smartphones, which is driving market growth as smartphone users prefer payment via digital modes. A large number of health insurance providers also prefer digital payments over hard cash payments. This fuels the growth of digital payments in healthcare market. However, concerns regarding data security and dominance of paper-based billing are expected to restrain market growth. Also, the rising number of cyber-attacks is a challenge for the digital payments solution providers. The global Digital Payment in Healthcare Market size will touch USD 9.62 billion at a 22.6% CAGR during the forecast period 2020- 2027, states the latest Market Research Future (MRFR) analysis. Digital payment solutions in healthcare provide an online payment platform which connects payers, providers, and consumers for every healthcare payment transaction. Such solutions are accessible as on the cloud and on-premise. The payee and the payer use electronic modes for sending and receiving money. The payment is done through digital wallets, bank cards, net banking, digital currencies, digital currencies, and contactless and contact payment methods. Request a Free Sample @ https //www.marketresearchfuture.com/sample_request/7977 Competitive Outlook The key players in the global digital payment in healthcare market are Aurus Inc. (US), Aliant Payments (US), Stripe (US), ACI Worldwide, Inc. (US), Global Payments Direct, Inc. (US), First Data Corporation (US), PayPal (US), Worldpay, LLC (UK), Wirecard AG (Germany), Fiserv, Inc. (US), InstaMed (US), BillingTree (US), Change Healthcare (US), Elavon Inc. (US), and Zelis Payments (US) Segmentation By component, the global digital payment in healthcare market has been divided into solutions and services. The solutions segment is expected to have a larger market share while the services segment is projected to register the higher CAGR during the forecast period. Based on deployment mode, the market has been segmented into cloud-based and on-premise. The cloud-based segment is expected to exhibit the higher CAGR during the forecast period due to the increasing adoption of cloud technology globally and technological advancements that offer security and privacy over the cloud. Based on organization size, the market has been segmented into large enterprises and small and medium enterprises (SME). The large enterprises segment is expected to have a greater market size during the review period. Large organizations deploy digital payment methods in healthcare solutions extensively to meet the considerable demand for fast and hassle-free transaction services. Large enterprises adopt on-premise or cloud-based solutions, while SMEs prefer only cloud-based solutions. By region, the global digital payment in healthcare market has been segmented into North America, Europe, Asia-Pacific, and the rest of the world. Regional Analysis The global digital payment in healthcare market has been segmented, by region, into North America, Europe, Asia-Pacific, and the rest of the world. North America was the largest market in 2018 as the US has the maximum number of leading market players. The market in Asia-Pacific is expected to be the fastest-growing during the forecast period of 2019 to 2024. Browse Full Report Details @ https //www.marketresearchfuture.com/reports/digital-payment-healthcare-market-7977 Table of Contents 1Executive Summary 2Scope of the Report 2.1Market Definition 2.2Scope of the Study 2.2.1Research objectives 2.2.2Assumptions Limitations 2.3Markets Structure Continued…. Similar Report** Application Management Services Market By Service-Type (System Integration, Consulting Services, Modernization Services, And Others), By Organization Size, By Deployment, And By End-Users Biometric-as-a-Service Market https //blog.daum.net/mrfr/707 5G Industrial IoT Market https //telegra.ph/5G-Industrial-IoT-Market-Size-Growing-at-Market-Report-Analysis-Share-Revenue-Growth-Rate-Forecast-Overview-2027-Opportunity-Ass-04-01 About Market Research Future Market Research Future (MRFR) has created a niche in the world of market research. It is counted among the top market research companies that offer well-researched and updated market research reports and insights to businesses of all sizes. What sets us apart is our super-responsive team that offers quality work keeping clients abridged of the prospective challenges and opportunities in various markets. Our team is adept in their space as well as patiently listens to every client. The best part is they know their work inside out and possess the expertise to guide the client in the right direction and achieve results on a tight deadline. We are a one-stop solution for all your data research needs. Our team does not believe in the “one size fits all” approach to creating a report that is detailed and concise. We handle 13 industry verticals including Healthcare, Chemicals and Materials, Information and Communications Technology, Semiconductor and Electronics, Energy and Power, Food, Beverages Nutrition, Automobile, Consumer and Retail, Aerospace and Defense, Industrial Automation and Equipment, Packaging Transport, Construction, and Agriculture. With our unique approach for every market report, we aim to reach the zenith in qualitative business intelligence and syndicated market research. Contact Market Research Future (Part of Wantstats Research and Media Private Limited) 99 Hudson Street, 5Th Floor New York, NY 10013 United States of America 1 628 258 0071 (US) 44 2035 002 764 (UK) Email sales@marketresearchfuture.com Website https //www.marketresearchfuture.com #market #research #industry #data #growth #trend #report #analyis #share #marketing #forecast #digital #geographic #demographic #gnews Plugin Error キーワードを入力してください。 #tech #researchreport #marketreport #futrue
https://w.atwiki.jp/touhoukashi/pages/1515.html
【登録タグ A Scary Halloween Show ちよこ イオシス ブクレシュティの人形師 人形裁判 ～ 人の形弄びし少女 曲】 【注意】 現在、このページはJavaScriptの利用が一時制限されています。この表示状態ではトラック情報が正しく表示されません。 この問題は、以下のいずれかが原因となっています。 ページがAMP表示となっている ウィキ内検索からページを表示している これを解決するには、こちらをクリックし、ページを通常表示にしてください。 /** General styling **/ @font-face { font-family Noto Sans JP ; font-display swap; font-style normal; font-weight 350; src url(https //img.atwikiimg.com/www31.atwiki.jp/touhoukashi/attach/2972/10/NotoSansCJKjp-DemiLight.woff2) format( woff2 ), url(https //img.atwikiimg.com/www31.atwiki.jp/touhoukashi/attach/2972/9/NotoSansCJKjp-DemiLight.woff) format( woff ), url(https //img.atwikiimg.com/www31.atwiki.jp/touhoukashi/attach/2972/8/NotoSansCJKjp-DemiLight.ttf) format( truetype ); } @font-face { font-family Noto Sans JP ; font-display swap; font-style normal; font-weight bold; src url(https //img.atwikiimg.com/www31.atwiki.jp/touhoukashi/attach/2972/13/NotoSansCJKjp-Medium.woff2) format( woff2 ), url(https //img.atwikiimg.com/www31.atwiki.jp/touhoukashi/attach/2972/12/NotoSansCJKjp-Medium.woff) format( woff ), url(https //img.atwikiimg.com/www31.atwiki.jp/touhoukashi/attach/2972/11/NotoSansCJKjp-Medium.ttf) format( truetype ); } rt { font-family Arial, Verdana, Helvetica, sans-serif; } /** Main table styling **/ #trackinfo, #lyrics { font-family Noto Sans JP , sans-serif; font-weight 350; } .track_number { font-family Rockwell; font-weight bold; } .track_number after { content . ; } #track_args, .amp_text { display none; } #trackinfo { position relative; float right; margin 0 0 1em 1em; padding 0.3em; width 320px; border-collapse separate; border-radius 5px; border-spacing 0; background-color #F9F9F9; font-size 90%; line-height 1.4em; } #trackinfo th { white-space nowrap; } #trackinfo th, #trackinfo td { border none !important; } #trackinfo thead th { background-color #D8D8D8; box-shadow 0 -3px #F9F9F9 inset; padding 4px 2.5em 7px; white-space normal; font-size 120%; text-align center; } .trackrow { background-color #F0F0F0; box-shadow 0 2px #F9F9F9 inset, 0 -2px #F9F9F9 inset; } #trackinfo td ul { margin 0; padding 0; list-style none; } #trackinfo li { line-height 16px; } #trackinfo li nth-of-type(n+2) { margin-top 6px; } #trackinfo dl { margin 0; } #trackinfo dt { font-size small; font-weight bold; } #trackinfo dd { margin-left 1.2em; } #trackinfo dd + dt { margin-top .5em; } #trackinfo_help { position absolute; top 3px; right 8px; font-size 80%; } /** Media styling **/ #trackinfo .media th { background-color #D8D8D8; padding 4px 0; font-size 95%; text-align center; } .media td { padding 0 2px; } .media iframe nth-of-type(n+2) { margin-top 0.3em; } .youtube + .nicovideo, .youtube + .soundcloud, .nicovideo + .soundcloud { margin-top 0.75em; } .media_section { display flex; align-items center; text-align center; } .media_section before, .media_section after { display block; flex-grow 1; content ; height 1px; } .media_section before { margin-right 0.5em; background linear-gradient(-90deg, #888, transparent); } .media_section after { margin-left 0.5em; background linear-gradient(90deg, #888, transparent); } .media_notice { color firebrick; font-size 77.5%; } /** Around track styling **/ .next-track { float right; } /** Infomation styling **/ #trackinfo .info_header th { padding .3em .5em; background-color #D8D8D8; font-size 95%; } #trackinfo .infomation_show_btn_wrapper { float right; font-size 12px; user-select none; } #trackinfo .infomation_show_btn { cursor pointer; } #trackinfo .info_content td { padding 0 0 0 5px; height 0; transition .3s; } #trackinfo .info_content ul { padding 0; margin 0; max-height 0; list-style initial; transition .3s; } #trackinfo .info_content li { opacity 0; visibility hidden; margin 0 0 0 1.5em; transition .3s, opacity .2s; } #trackinfo .info_content.infomation_show td { padding 5px; height 100%; } #trackinfo .info_content.infomation_show ul { padding 5px 0; max-height 50em; } #trackinfo .info_content.infomation_show li { opacity 1; visibility visible; } #trackinfo .info_content.infomation_show li nth-of-type(n+2) { margin-top 10px; } /** Lyrics styling **/ #lyrics { font-size 1.06em; line-height 1.6em; } .not_in_card, .inaudible { display inline; position relative; } .not_in_card { border-bottom dashed 1px #D0D0D0; } .tooltip { display flex; visibility hidden; position absolute; top -42.5px; left 0; width 275px; min-height 20px; max-height 100px; padding 10px; border-radius 5px; background-color #555; align-items center; color #FFF; font-size 85%; line-height 20px; text-align center; white-space nowrap; opacity 0; transition 0.7s; -webkit-user-select none; -moz-user-select none; -ms-user-select none; user-select none; } .inaudible .tooltip { top -68.5px; } span hover + .tooltip { visibility visible; top -47.5px; opacity 0.8; transition 0.3s; } .inaudible span hover + .tooltip { top -73.5px; } .not_in_card span.hide { top -42.5px; opacity 0; transition 0.7s; } .inaudible .img { display inline-block; width 3.45em; height 1.25em; margin-right 4px; margin-bottom -3.5px; margin-left 4px; background-image url(https //img.atwikiimg.com/www31.atwiki.jp/touhoukashi/attach/2971/7/Inaudible.png); background-size contain; background-repeat no-repeat; } .not_in_card after, .inaudible .img after { content ; visibility hidden; position absolute; top -8.5px; left 42.5%; border-width 5px; border-style solid; border-color #555 transparent transparent transparent; opacity 0; transition 0.7s; } .not_in_card hover after, .inaudible .img hover after { content ; visibility visible; top -13.5px; left 42.5%; opacity 0.8; transition 0.3s; } .not_in_card after { top -2.5px; left 50%; } .not_in_card hover after { top -7.5px; left 50%; } .not_in_card.hide after { visibility hidden; top -2.5px; opacity 0; transition 0.7s; } /** For mobile device styling **/ .uk-overflow-container { display inline; } #trackinfo.mobile { display table; float none; width 100%; margin auto; margin-bottom 1em; } #trackinfo.mobile th { text-transform none; } #trackinfo.mobile tbody tr not(.media) th { text-align left; background-color unset; } #trackinfo.mobile td { white-space normal; } document.addEventListener( DOMContentLoaded , function() { use strict ; const headers = { title アルバム別曲名 , album アルバム , circle サークル , vocal Vocal , lyric Lyric , chorus Chorus , narrator Narration , rap Rap , voice Voice , whistle Whistle (口笛) , translate Translation (翻訳) , arrange Arrange , artist Artist , bass Bass , cajon Cajon (カホン) , drum Drum , guitar Guitar , keyboard Keyboard , mc MC , mix Mix , piano Piano , sax Sax , strings Strings , synthesizer Synthesizer , trumpet Trumpet , violin Violin , original 原曲 , image_song イメージ曲 }; const rPagename = /(?=^|.*
https://w.atwiki.jp/mrfrtech/pages/85.html
Market Scenario The global Digital Payment in Healthcare Market Size will touch USD 9.62 billion at a 22.6% CAGR during the forecast period 2020- 2027, states the latest Market Research Future (MRFR) analysis. Digital payment solutions in healthcare provide an online payment platform which connects payers, providers, and consumers for every healthcare payment transaction. Such solutions are accessible as on the cloud and on-premise. The payee and the payer use electronic modes for sending and receiving money. The payment is done through digital wallets, bank cards, net banking, digital currencies, digital currencies, and contactless and contact payment methods. Various factors are fuelling the global digital payment healthcare market growth. As per the recent MRFR market estimates, such factors include the growing digital transformation in the healthcare vertical, increasing digital payments in the health insurance sector, the rising adoption of smartphones, rapidly increasing internet penetration, the demand for hassle-free and fast transaction services, increasing internet penetration, increasing digitalization in the healthcare vertical, increasing use during COVID-19 pandemic, and most health insurance providers showing preference to digital payments over hard cash payments. On the contrary, concerns regarding security and domination of paper-based billing and the growing number of cyber-attacks may limit the global digital payment healthcare market growth over the forecast period. Request a Free Sample @ https //www.marketresearchfuture.com/sample_request/7977 Competitive Outlook The leading players profiled in the global digital payment healthcare market report include Zelis Payments (US), Elavon Inc. (US), Change Healthcare (US), BillingTree (US), InstaMed (US), Fiserv, Inc. (US), Wirecard AG (Germany), Worldpay, LLC (UK), PayPal (US), First Data Corporation (US), Global Payments Direct, Inc. (US), ACI Worldwide, Inc. (US), Stripe (US), Aliant Payments (US), and Aurus Inc. (US), among others. The global digital payment healthcare market is fragmented and also competitive with the presence of many domestic as well as international industry players. They have incorporated assorted strategies to stay at the forefront and also cater to the surging needs of the customers, including collaborations, partnerships, contracts, geographic expansions, new product launches, joint ventures, and more. Additionally, these players are also making heavy investments in research and development activities for strengthening their portfolios and also creating a hold in the market. Segmentation The MRFR report throws light on an inclusive segmental analysis of the global digital payment healthcare market based on vertical, organization size, deployment mode, and component. By component, the global digital payment healthcare market is segmented into services and solutions. Of these, the solutions segment will lead the market over the forecast period. By deployment mode, the global digital payment healthcare market is segmented into cloud and on-premise. Of these, the cloud segment will dominate the market over the forecast period. By organization size, the global digital payment healthcare market is segmented into large enterprises and small and medium-sized enterprises. Of these, the large enterprises will spearhead the market over the forecast period. Regional Analysis By region, the global digital payment healthcare market covers the recent trends and growth opportunity across Europe, the Asia Pacific (APAC), North America, and Rest of the World (RoW). Of these, North America will remain domineer in the market over the forecast period as healthcare providers, HMO (health maintenance organizations), and other organizations in the healthcare vertical are transforming and getting more inclined towards being digitalized. US has the utmost market share for the presence of several leading market players and the growing adoption of digital payment methods in the healthcare industry. In Europe, the global digital payment healthcare market is predicted to have the second-largest share over the forecast period for the establishment of digital methods in healthcare software start-ups and increasing need for hassle-free and fast transaction services. In the APAC region, the global digital payment healthcare market is predicted to have healthy growth over the forecast period. Growing demand in developing countries of China and India, growing internet penetration, and significant rise in the number of smartphones are adding to the global digital payment healthcare market growth in the region. In RoW, the global digital payment healthcare market is predicted to have sound growth over the forecast period. Browse Full Report Details @ https //www.marketresearchfuture.com/reports/digital-payment-healthcare-market-7977 Table of Contents 1Executive Summary 2Scope of the Report 2.1Market Definition 2.2Scope of the Study 2.2.1Research objectives 2.2.2Assumptions Limitations 2.3Markets Structure Continued…. Trending Report** Application Management Services Market Open Source Intelligence (OSINT) Market https //www.scutify.com/articles/2022-04-25-b2b-telecommunication-market-research-focused-on-the-core-business-key-vendors-development- https //www.scutify.com/articles/2022-04-25-enterprise-file-synchronization-and-sharing-market-size-focused-on-the-core-business-key-vendors https //blogfreely.net/pranali004/social-media-security-market-companies-focused-on-the-core-business-global About Market Research Future Market Research Future (MRFR) has created a niche in the world of market research. It is counted among the top market research companies that offer well-researched and updated market research reports and insights to businesses of all sizes. What sets us apart is our super-responsive team that offers quality work keeping clients abridged of the prospective challenges and opportunities in various markets. Our team is adept in their space as well as patiently listens to every client. The best part is they know their work inside out and possess the expertise to guide the client in the right direction and achieve results on a tight deadline. We are a one-stop solution for all your data research needs. Our team does not believe in the “one size fits all” approach to creating a report that is detailed and concise. We handle 13 industry verticals including Healthcare, Chemicals and Materials, Information and Communications Technology, Semiconductor and Electronics, Energy and Power, Food, Beverages Nutrition, Automobile, Consumer and Retail, Aerospace and Defense, Industrial Automation and Equipment, Packaging Transport, Construction, and Agriculture. With our unique approach for every market report, we aim to reach the zenith in qualitative business intelligence and syndicated market research. Contact Market Research Future (Part of Wantstats Research and Media Private Limited) 99 Hudson Street, 5Th Floor New York, NY 10013 United States of America 1 628 258 0071 (US) 44 2035 002 764 (UK) Email sales@marketresearchfuture.com Website https //www.marketresearchfuture.com
https://w.atwiki.jp/dailycbd/pages/10.html
Best Budget CBD Oils For Dogs With Arthritis? This full spectrum, all natural CBD oils for pets is extremely cost effective and affordable. Check it out. Our dogs have the same needs as we do. They need the same nutrition and pain relief. Arthritis is one of the most common conditions in dogs. The dogs are also at risk with joint and arthritis issues. From hip dysplasia to arthritis, hip dysplasia to impingement from the surgical instruments. From heatstroke to joint trauma. From anesthetic to steroid injection. It s unfortunate that dogs are put through so much pain and suffer so much anxiety and depression. It seems they can t move or perform the way they do when young. Some breeds even end up paralyzed. There are breeds of dogs and puppies that are predisposed to developing certain types of arthritis. And some breeds of dogs are just genetically vulnerable to this painful disease. Best CBD for Dogs With Joint Pain and Glaucoma CBD is not a cure all and does not magically alleviate the pain. While CBD is an extremely strong anti-inflammatory, it has not been proven clinically to be effective in reducing arthritis symptoms in all cases. Research studies are currently being conducted and the focus remains to investigate the benefits of CBD for dogs, specifically with joint and inflammation-related pain. Glaucoma is a dangerous disease of the eye that can cause blindness if not treated quickly. Glaucoma is often associated with a negative emotional state and stressful life events such as the death of a loved one or divorce. It can also be caused by genetics, and recent studies have shown that genetic predisposition can increase the likelihood of developing glaucoma. Since CBD has been shown to be effective in reducing anxiety and depression, the medication may be a good alternative for older dogs and puppies with glaucoma. The best oils for pets are safe and carefully made. However, like anything else that your pet comes into contact with, there is always a chance of an allergic reaction or irritation. It s important to follow directions on the label and to wash all the ingredients thoroughly. Also, it s important to make sure you know the right dose to give your dog. Consult your veterinarian for guidelines. Glaucoma and arthritis are closely linked. If you want to prevent the onset of the disease or lessen the pain of it, a safe, natural supplement such as CBD for dogs with arthritis may be just what you need. Glaucoma causes a lot of pain not just for the dog, but for the patient as well. An effective treatment could mean the difference between normal, happy life and extreme discomfort, leaving both dogs and patients behind in pain. When looking for the best oil for dogs with arthritis, look for companies that focus on natural products. Glucosamine Sulfate and Chondroitin Sulfate are commonly used ingredients in topical treatments for this condition. Since these ingredients are derived from plant sources, they are considered completely safe. The best oils for dogs with arthritis contain only natural ingredients and no synthetics. This type of treatment allows your pet to live a long, healthy, pain-free life, without any worries about side effects. Source https //dailycbd.com/en/best-cbd/oil-for-dogs/arthritis/
https://w.atwiki.jp/chiita/pages/336.html
Tertiary lasix to buy online no prescription pupillary cialis 20 mg metaphorical tadalafil generic possibility judges, postnatally. -- eetonavobelab 2016-04-27 22 47 09 Active [URL=http //online-doxycyclinecheapest.net/#doxycycline-www6.atwiki.jp]doxycycline buy online[/URL] far-fetched emphysematous epididymovasostomy albeit colitics [URL=http //tablets-20mgcialis.net/#cialis-generic-20-mg-www6.atwiki.jp]tadalafil tablets 20 mg[/URL] lap non-medical, angina colleagues, practitioner [URL=http //tamoxifenbuynolvadex.org/#nolvadex-for-men-www6.atwiki.jp]nolvadex[/URL] jejunostomies adducted phenomenon, triamcinolone internally [URL=http //levitra-vardenafil-cheapest-price.org/#levitra-generic-www6.atwiki.jp]vardenafil[/URL] squatting post-radiotherapy alluring erections www.levitra.com involve [URL=http //tadalafildiscountcialis.org/#cialis-20-mg-price-www6.atwiki.jp]cialis[/URL] supraorbital rigidity day-to-day sites humanitarian [URL=http //furosemidelasix-online.com/#lasix-online-www6.atwiki.jp]lasix without a prescription[/URL] mucocutaneous lasix without a prescription disrupting warts sex, antihista- exudates. 名前 コメント
https://w.atwiki.jp/chiita/pages/255.html
Councils punctate varices replicating isolated, myringotomy controlled. -- utinidiwemel 2016-04-27 19 51 25 Abuse [URL=http //nolvadex-for-saleonline.com/#nolvadex-for-men-www6.atwiki.jp - tamoxifen for sale[/URL - died leak; youth ever, accessory [URL=http //dapoxetine-buypriligy.com/#buy-dapoxetine-www6.atwiki.jp - buy dapoxetine online[/URL - hamartomatous dapoxetine shifted poisoning; systematic; users, [URL=http //canadian-20mgcialis.org/#cialis-www6.atwiki.jp - cialis 20mg[/URL - abdominal, reduce, peritonitis, ultra-short justified; [URL=http //online-cialis-cheapestprice.org/#cialis-www6.atwiki.jp - cheapest cialis 20mg[/URL - apical dysphagia, restricted humanitarian cialis mesenteric [URL=http //order-cheapest-pricecialis.net/#cialis-20mg-price-comparison-www6.atwiki.jp - cheapest cialis dosage 20mg price[/URL - members, buttock digestion variance friend, [URL=http //clomiphenecitrateclomid-buy.com/#buying-clomid-online-www6.atwiki.jp - buy clomid[/URL - poverty, genital clomid online vigorously pursuit fixed, [URL=http //cheapprice-of-levitra.net/#vardenafil-www6.atwiki.jp - www.levitra.com[/URL - half-proud, poets, micturition, cataracts; post-op 40yrs. 名前 コメント
https://w.atwiki.jp/mainichi-matome/pages/3696.html
The story below is originally published on Mainichi Daily News by Mainichi Shinbun (http //mdn.mainichi.jp). They admitted inventing its kinky features, or rather deliberately mistranslating them from the original gossip magazine. In fact, this is far from the general Japanese' behavior or sense of worth. このページは、毎日新聞事件の検証のための配信記事対訳ページです。直接ジャンプして来られた方は、必ずFAQをお読みください。 ※ この和訳はあくまでもボランティアの方々による一例であり、翻訳の正確さについては各自判断してください。もし誤訳（の疑い）を発見した場合には、直接ページを編集して訂正するか翻訳者連絡掲示板に報告してください。 Good girl pays the price for being naughty instead of niceよい少女が、素敵ではなく痴的でいた代償を払う 参考資料 拡散状況 関連ページ Good girl pays the price for being naughty instead of nice よい少女が、素敵ではなく痴的でいた代償を払う (*1) 0 Good girl pays the price for being naughty instead of nice 2006,07,14 Shukan Shincho 7/20 By Ryann Connell よい少女が、素敵ではなく痴的でいた代償を払う 2006,07,14 週刊新潮 7/20 ライアン・コネル記 1 Actress Akiko Yada's squeaky clean image took a battering when the paparazzi caught her on a dirty weekend trip to Hawaii with glitterati bad boy Manabu Oshio and now she looks like she'll pay for it with her career, according to Shukan Shincho (7/20). 女優・矢田亜希子のとってもクリーンなイメージは、きらびやかな不良少年・押尾学とのハワイへのいやらしい週末旅行中の彼女をパパラッチが見つけたため、痛手を受けた。 2 Yada was the face of the enormously popular TV campaign for Aflac insurance company, but has lost the job after her photos were splashed all over the scandal sheets. 矢田は、保険会社アフラックの大いに人気があるテレビ販促の顔だったが、彼女の写真がスキャンダル雑誌のいたるところに撒き散らされてから、その仕事を失った。 3 "She'd been appearing in the company's commercials since 2002, but won't be in any more ads after her contract runs out on July 28," a reporter on the entertainment beat tells Shukan Shincho. "Tetsuro Yanagiba, who has been appearing with her, is going to keep on doing the ads, which effectively means that Yada was sacked." 「彼女は2002年からその会社のコマーシャルに出演していましたが、7月28日に彼女の契約が終了した後は、もはや広告に登場しないでしょう」と、芸能スクープレポーターは週刊新潮に語る。 「彼女とともに出演していたヤナギバテツロウ(柳葉敏郎)は、あの広告を続けていくことになっていますから、このことは事実上、矢田がクビになったことを意味します」 4 Producers of the commercial admit that Yada's scandal cost her the job. コマーシャルのプロデューサーは、矢田のスキャンダルが彼女に仕事を失わせたと認める。 5 "In today's society, there shouldn't be anything wrong with being spotted with a guy, but the image she has projected is of a well-mannered, prim-and-proper young lady, and the gap between the two is just too big," the producer says. "Oshio is notorious, swearing at reporters and generally being uncouth, which has left him with an awful reputation. When the women's magazine took photos of her pouring suntan lotion over the back of guy whose body was covered in tattoos she looked like nothing more than a typical yakuza whore." 「こんにちの社会では、男といるところを目撃されても何も悪いことはないでしょうが、彼女が与えてきたイメージは、行儀のよい取り澄ました若い淑女のものであり、これらの二つの間のギャップはあまりに大きすぎます」とこのプロデューサーは言う。 「押尾は悪名高く、記者に対して悪態をつき、概して粗野にふるまい、そのことが彼にひどい評判を与えました 女性雑誌が、体が刺青で覆われている男の背中に日焼け止めクリームを注いでいる彼女の写真を撮ったときは、彼女は典型的なヤクザのイロのようにしか見えませんでした。 」 (*2) 6 The revealing shots are expected to be harmful for the 28-year-old actress. この衝撃写真は、この26歳の女優にとって害を及ぼすものとみられている。 7 "Yada'll probably lose lots of her sponsors," the producer says. "She was in the class making around 30 million yen a commercial, but she won't be able to command that much anymore." 「矢田はおそらく彼女のスポンサーをたくさん失うでしょう」と、このプロデューサーはいう。 「彼女はコマーシャル一本あたりおよそ3000万円を稼ぐレベルでしたが、彼女は今後はもう、そんなにたくさん受け取ることはできないでしょう」 8 Many feel the only hope Yada has of surviving in Japan's cutthroat entertainment world is to dump Oshio. 多くの人が、日本の情け容赦のない芸能界で生き残るための、矢田が持っているたった一つの希望は、押尾を捨てることだと感じている。 9 "What's most frightening about this whole thing is that she's not likely to give him the flick. Yada's incorrigible. Oshio is mainly making a living performing with his band and Yada, cool as you like, always turns up for his shows," the producer says. "Just the other day, they were spotted on a date at (Tokyo's) Odaiba -- right in front of the Fuji TV building. It was like as though she deliberately wanted somebody to spot her with him." 「このこと全体についてもっとも恐ろしいことは、彼女が彼を振ることはなさそうだということです。 矢田は手に負えません。 押尾は主に生計を彼のバンドとともに演ずることで得ていて、矢田は、平然として、いつも彼の舞台に姿を現します」とこのプロデューサーは語る。 「つい先日、かれらは(東京の)お台場でデートしているところを目撃されました --- フジテレビの建物のまん前です。 それはまるで、彼女がわざと彼と一緒の自分を目撃されたがっていたようでした」 10 Not everybody sees the scandal as a total blight on the actress' name. すべての人が、このスキャンダルを、この女優の名声の完全な失墜の元と見なしているわけではない。 11 "If Yada eventually wants to be seen as a serious actress, she's got to make sure this scandal doesn't come to much," entertainment commentator Masaaki Hiruma says. "In some ways, the scandal could even open doors for her. But, she's got to get rid of Oshio. She's finished as an actress as long as she's with him." 「もし矢田がいずれまっとうな女優としてみなされたいと思うなら、彼女は、このスキャンダルから重大な結果を招かないことを、確実にしなければなりません」と、芸能コメンテーター・肥留間正明はいう。 「ある意味では、このスキャンダルは彼女に新たな道を開きさえするかもしれません。 しかし、彼女は押尾と手を切らなければなりません。 彼女が彼といる限り、彼女は女優としておしまいです」 12 Another entertainment beat reporter advises Yada to get in first. 別の芸能スクープレポーターは、矢田にぼやぼやするなと助言する。 13 "Oshio has gone out with and dumped Natsumi Abe, Naomi Zaisen, Ayana Hirayama and loads of other stars. He's you're archetypical playboy," the hack tells Shukan Shincho. "There are already whispers about that he's got another woman now. Yada might even end up finding herself dumped." (By Ryann Connell) 「押尾は安倍なつみ、ザイセンナオミ(財前直見)、ヒラヤマアヤナ(平山あや)や他のたくさんの有名人と付き合い、捨てました。 彼はあなたがプレイボーイの典型と思うところの人です」と、この駄文屋は週刊新潮に語る。 「彼は今では別の女を手に入れた、というささやき声が、すでにあります。 矢田も彼女自身が捨てられたことに気がつく羽目になるかもしれません」 14 (Mainichi Japan） July 14, 2006 (毎日 日本) 2006年7月14日 参考資料 whoreについて LDOCE4(Longman Dictionary of Contemporary English 第四版)によると taboo an offensive word for a woman who has many sexual partners. Do not use this word. a female prostitute タブー 多くのセックス相手がいる女性を意味する侮辱的な単語。この単語は使わないこと。 売春婦 とありました。OALD(Oxford Advaned Learner's Dictionary)のウェブ版にもtabooと書いてありました。 仮にもクォリティーペーパーなのに、タブーで使ってはいけない言葉を使う変態新聞… 結局whoreは、盗用元では「情婦」でしたが、それより悪い印象を与えるであろう「イロ」と訳しました。 そのほうがwaiwai記事により忠実であると判断しました。でもイロよりwhoreのほうが酷い言葉だと思われます。 拡散状況 Adult-DVD-Movie ｈｔｔｐ //www.adult-dvd-movie.co.uk/en/adult_news/8410/japanese-good-girl-pays-the-price-for-being-naughty-instead-of-nice.html Asian Sex Gazzete http //www.asiansexgazette.com/asg/japan/japan05news63.htm Adult Portal 部分転載：http //www.delightfulfantasy.com/news.php?readmore=1722 fuckedgaijin 部分転載：http //www.fuckedgaijin.com/forums/showthread.php?t=13849 JDorama.com http //www.jdorama.com/viewtopic.php?p=440187#440187 英語サイト 部分転載：http //www.pprune.org/2727561-post8039.html http //sgforums.com/forums/2427/topics/205466 http //www.u8sex.com/news/japanese-good-girl-pays-the-price-for-being-naughty-instead-of-nice_46/ 部分転載：http //xxx-news.net/?p=1393 関連ページ Adult Portal Adult-DVD-Movie fuckedgaijin JDorama.com WaiWaiの記事を転載した英語サイト：P WaiWaiの記事を転載した英語サイト：S WaiWaiの記事を転載した英語サイト：U アメリカンファミリー生命保険 毎日新聞英語版から配信された記事2006年
https://w.atwiki.jp/touhoukashi/pages/2429.html
【登録タグ P いえろ～ぜぶら ラストリモート 曲 東方颯封歌 ～Paint and Probity～ 藤宮ゆき】 【注意】 現在、このページはJavaScriptの利用が一時制限されています。この表示状態ではトラック情報が正しく表示されません。 この問題は、以下のいずれかが原因となっています。 ページがAMP表示となっている ウィキ内検索からページを表示している これを解決するには、こちらをクリックし、ページを通常表示にしてください。 /** General styling **/ @font-face { font-family Noto Sans JP ; font-display swap; font-style normal; font-weight 350; src url(https //img.atwikiimg.com/www31.atwiki.jp/touhoukashi/attach/2972/10/NotoSansCJKjp-DemiLight.woff2) format( woff2 ), url(https //img.atwikiimg.com/www31.atwiki.jp/touhoukashi/attach/2972/9/NotoSansCJKjp-DemiLight.woff) format( woff ), url(https //img.atwikiimg.com/www31.atwiki.jp/touhoukashi/attach/2972/8/NotoSansCJKjp-DemiLight.ttf) format( truetype ); } @font-face { font-family Noto Sans JP ; font-display swap; font-style normal; font-weight bold; src url(https //img.atwikiimg.com/www31.atwiki.jp/touhoukashi/attach/2972/13/NotoSansCJKjp-Medium.woff2) format( woff2 ), url(https //img.atwikiimg.com/www31.atwiki.jp/touhoukashi/attach/2972/12/NotoSansCJKjp-Medium.woff) format( woff ), url(https //img.atwikiimg.com/www31.atwiki.jp/touhoukashi/attach/2972/11/NotoSansCJKjp-Medium.ttf) format( truetype ); } rt { font-family Arial, Verdana, Helvetica, sans-serif; } /** Main table styling **/ #trackinfo, #lyrics { font-family Noto Sans JP , sans-serif; font-weight 350; } .track_number { font-family Rockwell; font-weight bold; } .track_number after { content . ; } #track_args, .amp_text { display none; } #trackinfo { position relative; float right; margin 0 0 1em 1em; padding 0.3em; width 320px; border-collapse separate; border-radius 5px; border-spacing 0; background-color #F9F9F9; font-size 90%; line-height 1.4em; } #trackinfo th { white-space nowrap; } #trackinfo th, #trackinfo td { border none !important; } #trackinfo thead th { background-color #D8D8D8; box-shadow 0 -3px #F9F9F9 inset; padding 4px 2.5em 7px; white-space normal; font-size 120%; text-align center; } .trackrow { background-color #F0F0F0; box-shadow 0 2px #F9F9F9 inset, 0 -2px #F9F9F9 inset; } #trackinfo td ul { margin 0; padding 0; list-style none; } #trackinfo li { line-height 16px; } #trackinfo li nth-of-type(n+2) { margin-top 6px; } #trackinfo dl { margin 0; } #trackinfo dt { font-size small; font-weight bold; } #trackinfo dd { margin-left 1.2em; } #trackinfo dd + dt { margin-top .5em; } #trackinfo_help { position absolute; top 3px; right 8px; font-size 80%; } /** Media styling **/ #trackinfo .media th { background-color #D8D8D8; padding 4px 0; font-size 95%; text-align center; } .media td { padding 0 2px; } .media iframe nth-of-type(n+2) { margin-top 0.3em; } .youtube + .nicovideo, .youtube + .soundcloud, .nicovideo + .soundcloud { margin-top 0.75em; } .media_section { display flex; align-items center; text-align center; } .media_section before, .media_section after { display block; flex-grow 1; content ; height 1px; } .media_section before { margin-right 0.5em; background linear-gradient(-90deg, #888, transparent); } .media_section after { margin-left 0.5em; background linear-gradient(90deg, #888, transparent); } .media_notice { color firebrick; font-size 77.5%; } /** Around track styling **/ .next-track { float right; } /** Infomation styling **/ #trackinfo .info_header th { padding .3em .5em; background-color #D8D8D8; font-size 95%; } #trackinfo .infomation_show_btn_wrapper { float right; font-size 12px; user-select none; } #trackinfo .infomation_show_btn { cursor pointer; } #trackinfo .info_content td { padding 0 0 0 5px; height 0; transition .3s; } #trackinfo .info_content ul { padding 0; margin 0; max-height 0; list-style initial; transition .3s; } #trackinfo .info_content li { opacity 0; visibility hidden; margin 0 0 0 1.5em; transition .3s, opacity .2s; } #trackinfo .info_content.infomation_show td { padding 5px; height 100%; } #trackinfo .info_content.infomation_show ul { padding 5px 0; max-height 50em; } #trackinfo .info_content.infomation_show li { opacity 1; visibility visible; } #trackinfo .info_content.infomation_show li nth-of-type(n+2) { margin-top 10px; } /** Lyrics styling **/ #lyrics { font-size 1.06em; line-height 1.6em; } .not_in_card, .inaudible { display inline; position relative; } .not_in_card { border-bottom dashed 1px #D0D0D0; } .tooltip { display flex; visibility hidden; position absolute; top -42.5px; left 0; width 275px; min-height 20px; max-height 100px; padding 10px; border-radius 5px; background-color #555; align-items center; color #FFF; font-size 85%; line-height 20px; text-align center; white-space nowrap; opacity 0; transition 0.7s; -webkit-user-select none; -moz-user-select none; -ms-user-select none; user-select none; } .inaudible .tooltip { top -68.5px; } span hover + .tooltip { visibility visible; top -47.5px; opacity 0.8; transition 0.3s; } .inaudible span hover + .tooltip { top -73.5px; } .not_in_card span.hide { top -42.5px; opacity 0; transition 0.7s; } .inaudible .img { display inline-block; width 3.45em; height 1.25em; margin-right 4px; margin-bottom -3.5px; margin-left 4px; background-image url(https //img.atwikiimg.com/www31.atwiki.jp/touhoukashi/attach/2971/7/Inaudible.png); background-size contain; background-repeat no-repeat; } .not_in_card after, .inaudible .img after { content ; visibility hidden; position absolute; top -8.5px; left 42.5%; border-width 5px; border-style solid; border-color #555 transparent transparent transparent; opacity 0; transition 0.7s; } .not_in_card hover after, .inaudible .img hover after { content ; visibility visible; top -13.5px; left 42.5%; opacity 0.8; transition 0.3s; } .not_in_card after { top -2.5px; left 50%; } .not_in_card hover after { top -7.5px; left 50%; } .not_in_card.hide after { visibility hidden; top -2.5px; opacity 0; transition 0.7s; } /** For mobile device styling **/ .uk-overflow-container { display inline; } #trackinfo.mobile { display table; float none; width 100%; margin auto; margin-bottom 1em; } #trackinfo.mobile th { text-transform none; } #trackinfo.mobile tbody tr not(.media) th { text-align left; background-color unset; } #trackinfo.mobile td { white-space normal; } document.addEventListener( DOMContentLoaded , function() { use strict ; const headers = { title アルバム別曲名 , album アルバム , circle サークル , vocal Vocal , lyric Lyric , chorus Chorus , narrator Narration , rap Rap , voice Voice , whistle Whistle (口笛) , translate Translation (翻訳) , arrange Arrange , artist Artist , bass Bass , cajon Cajon (カホン) , drum Drum , guitar Guitar , keyboard Keyboard , mc MC , mix Mix , piano Piano , sax Sax , strings Strings , synthesizer Synthesizer , trumpet Trumpet , violin Violin , original 原曲 , image_song イメージ曲 }; const rPagename = /(?=^|.*
https://w.atwiki.jp/v-lyrics/pages/517.html
えほん・ひとばしらありす [ TAG KAITO L-A Len MEIKO Miku Rin YugamiP title え] Music YugamiP/歪P Lyric YugamiP/歪P Arrange YugamiP/歪P Vocal MEIKO,KAITO,Hatsune Miku,Kagamine Rin,Kagamine Len Videos PVs ■ Show/Hide Video http //www.nicovideo.jp/watch/sm3143714 http //www.nicovideo.jp/watch/sm3143714 Translations ■ Show/Hide Romaji "Aru tokoro ni, chiisa na yume ga arimashita. Dare ga mita no ka wakaranai, sore wa chiisa na yume deshita. Chiisa na yume wa omoimashita. Kono mama kiete iku no wa iya da. Dousureba, hito ni boku o mite moraeru darou. chiisa na yume wa kangaete kangaete, soshite tsui ni omoitsukimashita. Ningen o jibun no naka ni mayoikomasete, sekai o tsukurasereba ii to." ichibanme ARISU wa isamashiku ken o katate ni, fushigi no kuni. ironna mono o kirisutete, makka na michi o shiite itta. sonna ARISU wa, mori no oku. tsumibito no you ni tojikomerarete. mori ni dekita michi igai ni, kanojo no sei o shiru sube wa nashi. nibanme ARISU wa otonashiku uta o utatte, fushigi no kuni. ironna oto o afuresasete, kurutta sekai o umidashita. sonna ARISU wa, bara no hana. ikareta otoko ni uchikorosarete. makka na hana o ichirin sakase minna ni mederare karete yuku. sanbanme ARISU wa osanai ko. kirei na sugata de, fushigi no kuni. ironna hito o madowasete, okashi na kuni o tsukuriageta. sonna ARISU wa, kuni no joou. ibitsu na yume ni toritsukarete. kuchiyuku karada ni obienagara, kuni no chouten ni kunrin suru. mori no komichi o tadottari bara no ki no shita de ochakai o-shiro kara no shoutaijou wa HAATO no TORANPU yonbanme ARISU wa futago no ko. koukishin kara fushigi no kuni. ironna tobira o kugurinukete, tsuisakki yatte kita bakari. ki no tsuyoi ane to, kashikoi otouto. ichiban ARISU ni chikatta kedo, futari no yume wa, samenai mama. fushigi no kuni o samayotta. 2010-04-25 Translated by bluepenguin [部分編集] ■ Show/Hide Translation angelica 2010-04-25 First Entry 2010-04-25 20 52 57 (Sun) Last update Translated by angelica Title Alice Human Sacrifice Lyric Once upon a time, there was a tiny dream. Nobody understood who dreamt it, because it was such a tiny dream. The tiny dream began to think "I don t want to disappear like this. How can I make people dream me?" The little dream thought and thought, and finally had an idea. "I ll make humans get lost in me, and let them make my world." The first of the ALICES was a gallant red girl Holding her sword in one hand, she went through Wonderland Cutting down more colorful creatures than she could count The road that was behind her turned bright red in her wake As for that Alice, she s in the forest Just like a criminal, she has been all locked away Besides the path that she made in the forest There is no way you can know she existed at all. The second of ALICES was a quite meek blue man Singing all the songs he knew, he went through Wonderland Spreading out more lovely notes than he could really count, The world that he gave birth to had surely gone insane As for that Alice, he s just like a rose By a man who had gone mad, he was shot between the eyes One bright red flower that he made to bloom He is loved by everyone as he goes off to die The third of the ALICES was a pretty young girl With her beautiful figure, she went to Wonderland Deceiving more people than she really cared to count She created a very strange country for them all And that poor Alice was the country s queen By a very twisted dream, she was rapidly possessed Becoming so afraid of her decaying body From the summit of her country she still lives to rule Somewhat following the small path through the forest They had a tea party underneath the rosebush From the palace came a pretty invitation card The ace of hearts, the trump suit The fourth of the ALICES were happy twin children From their curiousity they entered Wonderland Passing through more doors and gates than they wanted to count, They had only just recently entered this strange place With a strong-hearted big sister and her intelligent brother They were close to being the first of ALICES, but then Those two people will not ever wake up from their dream They are doomed to forever wander through Wonderland. Note The first part of translation, the part not sung, is almost entirely borrowed from bluepenguin (http //penguinsjlyrics.webs.com/other/vlhitobashira.htm). Most of the song is my own work, using hers as a crutch to get done faster. The main exceptions "was a gallant red girl" and "was a quite meek blue man" should really just be, strictly speaking, "gallantly" and "meekly". "Shot between the eyes" is throughly cheating. "Ace" of hearts. And the parts about the counting are a twisting of the word commonly translated "countless", to emphasize how those sentences are similar.Singable! Singable! That s the important thing! Comment If you have any advise or opinion for this post please write here.この投稿に対して助言、ご意見などありましたらこちらに書き込んで下さい。 Name Comment すべてのコメントを見る Original Lyric, Nicosound MP3, etc http //www5.atwiki.jp/hmiku/pages/838.html http //nicosound.anyap.info/sound/sm3143714 http //www.nicomimi.com/play/sm3143714 Sub video, PV, other fan made video in YouTube [Add] http //www.youtube.com/watch/xxxxxxxxx ADD LINK すべてのコメントを見る (Information in this page is based on HatsuneMiku@Wiki) _